Richard Burr: “It is not unreasonable for us to consider whether we require it in higher education.”

It is time that we hold the FDA accountable.

I question whether the agreements both passed and proposed reflect a good deal for patients they are designed to serve.

And the 12 that Roy has been in. But I have got to say that I never questioned whether Roy was going to be prepared, whether he was going to attend, whether he was going to absorb what he heard, and, more importantly, whether he was going…

I will tell you right now, Congress is going to require accountability in the new program.